SpliSense secures $28.5 million in funding to advance mRNA-altering pipeline for treatment of CF 13.05.21 | Meir Orbach
Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria 26.01.21 | Meir Orbach